LAB vs WFC · rev $174.4M vs P/E 15, $272.05B cap
Standard Biotools Inc (LAB) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
WFC does not have a complete income-statement cache yet.
LAB currently screens at market cap $317.1M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the LAB and WFC stock pages for the full models.
Not investment advice.